• FDA drops warning letter on Lupin sterile drug operations fiercepharma
    March 15, 2019
    Lupin has indicated it has received another FDA warning letter as regulatory issues continue to pile up for the Indian drugmaker. The most recent letter comes just four months after the agency issued a two-plant warning and told the drugmaker it needs to
PharmaSources Customer Service